These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11786386)

  • 21. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene.
    López-Rovira T; Chalaux E; Massagué J; Rosa JL; Ventura F
    J Biol Chem; 2002 Feb; 277(5):3176-85. PubMed ID: 11700304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.
    Pouliot F; Blais A; Labrie C
    Cancer Res; 2003 Jan; 63(2):277-81. PubMed ID: 12543773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations.
    Benchabane H; Wrana JL
    Mol Cell Biol; 2003 Sep; 23(18):6646-61. PubMed ID: 12944489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.
    Ishida W; Hamamoto T; Kusanagi K; Yagi K; Kawabata M; Takehara K; Sampath TK; Kato M; Miyazono K
    J Biol Chem; 2000 Mar; 275(9):6075-9. PubMed ID: 10692396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL; Herrera RE; Yee D
    Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation.
    Ghosh-Choudhury N; Woodruff K; Qi W; Celeste A; Abboud SL; Ghosh Choudhury G
    Biochem Biophys Res Commun; 2000 Jun; 272(3):705-11. PubMed ID: 10860819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smad1 and Smad4 are components of the bone morphogenetic protein-4 (BMP-4)-induced transcription complex of the Xvent-2B promoter.
    Henningfeld KA; Rastegar S; Adler G; Knöchel W
    J Biol Chem; 2000 Jul; 275(29):21827-35. PubMed ID: 10791953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
    Kawai S; Faucheu C; Gallea S; Spinella-Jaegle S; Atfi A; Baron R; Roman SR
    Biochem Biophys Res Commun; 2000 May; 271(3):682-7. PubMed ID: 10814522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression.
    Wan M; Shi X; Feng X; Cao X
    J Biol Chem; 2001 Mar; 276(13):10119-25. PubMed ID: 11139569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway.
    Izumi M; Fujio Y; Kunisada K; Negoro S; Tone E; Funamoto M; Osugi T; Oshima Y; Nakaoka Y; Kishimoto T; Yamauchi-Takihara K; Hirota H
    J Biol Chem; 2001 Aug; 276(33):31133-41. PubMed ID: 11408477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.
    Kowanetz M; Valcourt U; Bergström R; Heldin CH; Moustakas A
    Mol Cell Biol; 2004 May; 24(10):4241-54. PubMed ID: 15121845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression.
    Hong C; Kim HA; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2002 Aug; 23(8):1297-305. PubMed ID: 12151347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?
    Glister C; Richards SL; Knight PG
    Endocrinology; 2005 Apr; 146(4):1883-92. PubMed ID: 15625241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad signaling in mesenchymal and chondroprogenitor cells.
    Hatakeyama Y; Nguyen J; Wang X; Nuckolls GH; Shum L
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():13-8. PubMed ID: 12925604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells.
    Wen XZ; Miyake S; Akiyama Y; Yuasa Y
    Biochem Biophys Res Commun; 2004 Mar; 316(1):100-6. PubMed ID: 15003517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription.
    Li L; Xin H; Xu X; Huang M; Zhang X; Chen Y; Zhang S; Fu XY; Chang Z
    Mol Cell Biol; 2004 Jan; 24(2):856-64. PubMed ID: 14701756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells.
    Nakayama K; Tamura Y; Suzawa M; Harada S; Fukumoto S; Kato M; Miyazono K; Rodan GA; Takeuchi Y; Fujita T
    J Bone Miner Res; 2003 May; 18(5):827-35. PubMed ID: 12733721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.